Australian court awards Vioxx payout
This article was originally published in Scrip
Executive Summary
The Federal Court of Australia has ordered Merck & Co to pay A$287,912 ($259,400) plus interest to a 59 year-old man who suffered a heart attack after taking the arthritis pain relief drug Vioxx (rofecoxib), in the first such trial outside the US.